Thyroid disease and pulmonary arterial hypertension (PAH) in patients treated with prostacyclin

被引：0
|
作者：
Ferris, AM [1 ]
Morse, JH [1 ]
Jacobs, T [1 ]
Rosenzweig, EB [1 ]
Aranoff, GS [1 ]
Barst, RJ [1 ]
机构：
[1] Columbia Univ, New York, NY USA
来源：
CIRCULATION | 2000年 / 102卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2075
引用
收藏
页码：426 / 427
页数：2
相关论文
共 50 条
  • [1] AVOIDING THYROID TESTING FATIGUE: PULMONARY ARTERIAL HYPERTENSION (PAH) IN A PATIENT WITH HASHIMOTO DISEASE
    Vlachos, Elena M.
    Friedman, Samuel H.
    Sese, Denise A.
    CHEST, 2022, 162 (04) : 2445A - 2445A
  • [2] Pulmonary arterial hypertension and thyroid disease
    Silva, Denise Rossato
    Gazzana, Marcelo Basso
    John, Angela Beatriz
    Siqueira, Debora Rodrigues
    Silva Maia, Ana Luiza
    Menna Barreto, Sergio Saldanha
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2009, 35 (02) : 179 - 185
  • [3] Pulmonary arterial hypertension and thyroid disease
    Ferris, A
    Jacobs, T
    Widlitz, A
    Barst, RJ
    Morse, JH
    CHEST, 2001, 119 (06) : 1980 - 1981
  • [4] Prostacyclin for Pulmonary Arterial Hypertension
    Cooper, Adam S.
    CRITICAL CARE NURSE, 2022, 42 (02) : 79 - 81
  • [5] Prostacyclin for pulmonary arterial hypertension
    Barnes, Hayley
    Yeoh, Hui-Ling
    Fothergill, Toby
    Burns, Andrew
    Humbert, Marc
    Williams, Trevor
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (05):
  • [6] Treatment and survival in patients with pulmonary arterial hypertension (PAH)
    Kremers, Hilal Maradit
    Slusser, Joshua P.
    Scott, Christopher G.
    Primatesta, Paola
    McGoon, Michael D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S25 - S25
  • [7] Excess Prostacyclin Syndrome in Patients with Pulmonary Arterial Hypertension Treated with Chronic Parenteral Prostacyclin Therapy: Case Reports
    Martinez Ceren, P.
    Wu, S.
    Fernandes, T.
    Papamatheakis, D. G.
    Poch, D. S.
    Yang, J.
    Lombardi, S.
    Rodriguez, C.
    Kim, N. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [8] Early Versus Late Initiation of Treatment with Prostacyclin-Class Therapy in Patients with Pulmonary Arterial Hypertension (PAH)
    Anguiano, R. H.
    Stafkey-Mailey, D.
    Saundankar, V.
    Dean, B.
    Classi, P.
    Gordon, K.
    Nails, A.
    Nelsen, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [9] Prognostic value of echocardiographic parameters in patients with pulmonary arterial hypertension (PAH) treated with targeted therapies
    Beciani, E.
    Palazzini, M.
    Bachetti, C.
    Sgro, F.
    Conficoni, E.
    Gotti, E.
    Mazzanti, G.
    Manes, A.
    Branzi, A.
    Galie, N.
    EUROPEAN HEART JOURNAL, 2010, 31 : 7 - 8
  • [10] Autoimmune Thyroid Disease After Initiation Of Epoprostenol For Treatment Of Pulmonary Arterial Hypertension (pah): A Case Series
    Menon, A. Ajakumar
    Lee, S. L.
    Braverman, L. E.
    Farber, H. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
12345